The ageing heart: The systemic and coronary circulation

Heart

Volumn 104, Issue 5, 2018, Pages 370-376

  Nanayakkara, Shane ^a,b,c   Marwick, Thomas H ^a,b   Kaye, David M ^a,b,c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

cardiac procedures and therapy; cardiac risk factors and prevention; global disease patterns; heart disease; myocardial disease basic science

Indexed keywords

ATENOLOL PLUS CHLORTALIDONE; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; PLACEBO;

ACUTE CORONARY SYNDROME; AGING; ARTERIAL STIFFNESS; CARDIOVASCULAR DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; FRACTIONAL FLOW RESERVE; FRAILTY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; STABLE ANGINA PECTORIS; SYSTEMIC CIRCULATION; WALKING SPEED; AGE; AGED; CARDIOVASCULAR SYSTEM; FRAIL ELDERLY; GERIATRIC ASSESSMENT; MIDDLE AGED; PROGNOSIS; RISK FACTOR; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CORONARY CIRCULATION; FRAIL ELDERLY; FRAILTY; GERIATRIC ASSESSMENT; HUMANS; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 85041386689     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2017-312114     Document Type: Review

References (50)

1. As G, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127.
2. Fuster V. Changing demographics: a new approach to global health care due to the aging population. J Am Coll Cardiol 2017;69:3002-5.
3. Rich MW, Chyun DA, Skolnick AH, et al. Knowledge gaps in cardiovascular care of the older adult population. Circulation 2016:CIR.0000000000000380.
4. Ahluwalia SC, Gross CP, Chaudhry SI, et al. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med 2011;26:1145-51.
5. Rowe R, Iqbal J, Murali-Krishnan R, et al. Role of frailty assessment in patients undergoing cardiac interventions. Open Heart 2014;1:e000033.
6. Sergi G, Veronese N, Fontana L, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study. J Am Coll Cardiol 2015;65:976-83.
7. Singh M, Rihal CS, Lennon RJ, et al. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization. Circ Cardiovasc Qual Outcomes 2011;4:496-502.
8. Williamson JD, Supiano MA, Applegate WB, et al. SPRINT Research Group. Intensive vs Standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 Years: a randomized clinical trial. JAMA 2016;315:2673-82.
9. James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults. JAMA 2014;2014:507.
10. Chobanian AV. Hypertension in 2017-What Is the right target? JAMA 2017;317:579.
11. Chung HY, Sung B, Jung KJ, et al. The molecular inflammatory process in aging. Antioxid Redox Signal 2006;8:572-81.
12. Paneni F, Canestro CD, Libby P, et al. The Aging cardiovascular system: understanding it at the cellular and clinical level. 2016.
13. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007;50:197-203.
14. McEniery CM, Yasmin, Hall IR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-60.
15. Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 1991;139:1119-29.
16. Meaume S, Benetos A, Henry OF, et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001;21:2046-50.
17. Staessen JA, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539.
18. Hansen TW, Jeppesen J, Rasmussen S, et al. Ambulatory blood pressure and mortality: a population-based study. Hypertension 2005;45:499-504.
19. Burr ML, Dolan E, O'Brien EW, et al. The value of ambulatory blood pressure in older adults: the dublin outcome study. Age Ageing 2008;37:201-6.
20. Bulpitt CJ, Beckett N, Peters R, et al. Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension 2013;61:89-94.
21. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64 http:// www. ncbi. nlm. nih. gov/ pubmed/ 2046107.
22. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64.
23. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.
24. Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. J Am Coll Cardiol 2017;69:486-93.
25. Charlesworth CJ, Peralta CA, Odden MC. Functional status and antihypertensive therapy in older adults: a new perspective on old data. Am J Hypertens 2016;29:690-5.
26. Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the Hypertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med 2015;13:78.
27. Odden MC, Coxson PG, Moran A, et al. The impact of the aging population on coronary heart disease in the United States. Am J Med 2011;124:827-33.
28. Wang JC, Aging BM. Aging and atherosclerosis. Circ Res 2012;111:245-59.
29. Wei K, Diaz-Trelles R, Liu Q, et al. Developmental origin of age-related coronary artery disease. Cardiovasc Res 2015;107:287-94.
30. Nguyen PK, Terashima M, Fair JM, et al. Physical activity in older subjects is associated with increased coronary vasodilation: the ADVANCE study. JACC Cardiovasc Imaging 2011;4:622-9.
31. Epstein SE, Lassance-Soares RM, Faber JE, et al. Effects of aging on the collateral circulation, and therapeutic implications. Circulation 2012;125:3211-9.
32. Milner KA, Vaccarino V, Arnold AL, et al. Gender and age differences in chief complaints of acute myocardial infarction (Worcester Heart Attack Study). Am J Cardiol 2004;93:606-8.
33. Sheifer SE, Rathore SS, Gersh BJ, et al. Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation 2000;102:1651-6 http://www. ncbi. nlm. nih. gov/ pubmed/ 11015343.
34. Montalescot G, Sechtem U, Achenbach S, et al. ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013;2013:2949-3003.
35. Tota-Maharaj R, Blaha MJ, McEvoy JW, et al. Coronary artery calcium for the prediction of mortality in young adults 75 years old. Eur Heart J 2012;33.
36. Budoff MJ, Nasir K, McClelland RL, et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53:345-52.
37. Lim HS, Tonino PA, De Bruyne B, et al. The impact of age on fractional flow reserveguided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. Int J Cardiol 2014;177:66-70.
38. Jin X, Lim HS, Tahk SJ, et al. Impact of age on the functional significance of intermediate epicardial artery disease. Circ J 2016;80:1583-9.
39. Lee JM, Hwang D, Park J, et al. Physiologic mechanism of discordance between instantaneous wave-free ratio and fractional flow reserve: Insight from (13) N-ammonium positron emission tomography. Int J Cardiol 2017;243:91-4.
40. Kandzari DE, Roe MT, Chen AY, et al. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2005;149:474-81.
41. Alexander KP, Roe MT, Chen AY, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005;46:1479-87.
42. Ibanez B, James S, Agewall S, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2017;2017:2569-619.
43. Aldermann ETIME Investigators ECSS; TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 2001;358:951-7.
44. Bucholz EM, Butala NM, Normand ST, et al. Association of guideline-based admission treatments and life expectancy after myocardial infarction in elderly medicare beneficiaries. J Am Coll Cardiol 2016;67:2378-91.
45. Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet 2016;387:1057-65.
46. Savonitto S, Cavallini C, Petronio AS, et al. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. JACC Cardiovasc Interv 2012;5:906-16.
47. Bueno H, Betriu A, Heras M, et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J 2011;32:51-60.
48. Ascione R, Rees K, Santo K, et al. Coronary artery bypass grafting in patientsover 70 years old: The influence of age and surgical technique onearly and mid-term clinical outcomes. EuropeanJournal of Cardio-thoracic Surgery. Oxford: Oxford University Press, 2002:124-8.
49. Shan L, Saxena A, McMahon R, et al. Coronary Artery Bypass Graft Surgery in the Elderly. Circulation 2013;128.
50. Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol 2010;56:1668-76.